Clinical Study
Temozolomide Therapy for Aggressive Pituitary Tumors: Results in a Small Series of Patients from Argentina
Table 1
Main clinical traits of 6 patients with intention-to-treat with temozolomide.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PRLCa: prolactin carcinoma; GH-oma: somatotropinoma; CNFPA: clinically nonfunctioning pituitary adenoma; NS: Nelson’ syndrome; CD: Cushing’s disease; RxT: radiotherapy; CAB: cabergoline; SSAs: somatostatin analogs; KNZ: ketoconazole. |